Streetbeat News

Analyst Ratings

NOK

JP Morgan analyst Sandeep Deshpande maintains an Overweight rating on Nokia (NYSE:NOK) but lowers the price target from $7.24 to $6.85.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 4:13 pm

JELD

Truist Securities analyst Keith Hughes has maintained a 'Hold' rating on JELD-WEN Holding (NYSE:JELD) and lowered the price target from $17 to $14.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 4:12 pm

GDOT

Truist Securities analyst Andrew Quail has maintained a 'Buy' rating on Green Dot (NYSE:GDOT), but lowered the price target from $24 to $17.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 4:10 pm

NAVI

JP Morgan analyst Richard Shane has maintained an 'Underweight' rating on Navient (NASDAQ:NAVI) and lowered the price target from $19.5 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 4:10 pm

MTD

JP Morgan analyst Tycho Peterson has maintained a Neutral rating on Mettler-Toledo Intl (NYSE:MTD) and lowered the price target from $1300 to $1100.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 4:09 pm

FBIN

Truist Securities analyst Keith Hughes has maintained a 'Buy' rating on Fortune Brands (NYSE:FBIN) but lowered the price target from $90 to $75.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 4:08 pm

FND

Truist Securities analyst Keith Hughes has maintained a 'Buy' rating on Floor & Decor Holdings (NYSE:FND) but lowered the price target from $120 to $110.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 4:07 pm

PODD

JP Morgan analyst Robbie Marcus has maintained an Overweight rating on Insulet (NASDAQ:PODD) but lowered the price target from $325 to $162.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 4:06 pm

FI

Truist Securities analyst Andrew Jeffrey maintains a 'Hold' rating on Fiserv (NYSE:FI) but has lowered the price target from $130 to $120.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 4:05 pm

INSP

JP Morgan analyst Robbie Marcus has maintained an Overweight rating on Inspire Medical Systems (NYSE:INSP) but lowered the price target from $340 to $181.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 4:04 pm